AS

Ayman Sahli

Director Director DIN 02680724
DIN 02680724 First appointment Apr 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2009
Shareholding value Locked Premium profile

About Ayman Sahli

Data last updated:

Ayman Sahli has 17 years in corporate governance. Formerly with 1 company, such as Sms Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02680724
Primary Designation Director
First Appointment 30 Apr 2009
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Sms Pharmaceuticals Limited L24239TG1987PLC008066
Nominee Director30 Apr 20091987Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sms Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Ayman Sahli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayman Sahli

Ayman Sahli has 17 years in corporate governance. Formerly with 1 company, such as Sms Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Ayman Sahli is associated with 0 companies as a director.

Ayman Sahli has expertise in General Business.

Ayman Sahli has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available